CXCR4 and hematopoietic and lymphoid system neoplasm: CXCR4 ERT also caused desired bone marrow ablation and has therefore been incorporated in the therapeutic algorithm of advanced blood cancer patients (allogenic/autologous HSCT following CXCR4 ERT along with successful engraftment) [12, 15, 49].